Clinical Trials Browser

Phase 3 × Withdrawn × Esophageal Neoplasms × Clear all

NCT02326779 2021-04-27

Low-dose Aspirin Therapy for Esophageal Cancer

Phase 3 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03881111 2020-02-11

KEYNOTE-590

Phase 3 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT01998347 2015-11-20

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

Phase 3 Withdrawn

Gastrointestinal

Esophageal Neoplasms